Report Detail

Pharma & Healthcare Global G-CSF and G-CSF Biosimilars Market Professional Survey Report 2019

  • RnM3743057
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global G-CSF and G-CSF Biosimilars Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of G-CSF and G-CSF Biosimilars

      • 1.1 Definition of G-CSF and G-CSF Biosimilars
      • 1.2 G-CSF and G-CSF Biosimilars Segment by Type
        • 1.2.1 Global G-CSF and G-CSF Biosimilars Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Blood Disorders
        • 1.2.3 Oncology Diseases
        • 1.2.4 Chronic And Autoimmune Diseases
        • 1.2.5 Growth Hormone Deficiencies
      • 1.3 G-CSF and G-CSF Biosimilars Segment by Applications
        • 1.3.1 Global G-CSF and G-CSF Biosimilars Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Human Growth Hormone
        • 1.3.3 Erythropoietin
        • 1.3.4 Monoclonal Antibodies
        • 1.3.5 Insulin
        • 1.3.6 Interferon
      • 1.4 Global G-CSF and G-CSF Biosimilars Overall Market
        • 1.4.1 Global G-CSF and G-CSF Biosimilars Revenue (2014-2025)
        • 1.4.2 Global G-CSF and G-CSF Biosimilars Production (2014-2025)
        • 1.4.3 North America G-CSF and G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.4 Europe G-CSF and G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.5 China G-CSF and G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.6 Japan G-CSF and G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia G-CSF and G-CSF Biosimilars Status and Prospect (2014-2025)
        • 1.4.8 India G-CSF and G-CSF Biosimilars Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of G-CSF and G-CSF Biosimilars
      • 2.3 Manufacturing Process Analysis of G-CSF and G-CSF Biosimilars
      • 2.4 Industry Chain Structure of G-CSF and G-CSF Biosimilars

      3 Development and Manufacturing Plants Analysis of G-CSF and G-CSF Biosimilars

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global G-CSF and G-CSF Biosimilars Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of G-CSF and G-CSF Biosimilars
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 G-CSF and G-CSF Biosimilars Production and Capacity Analysis
      • 4.2 G-CSF and G-CSF Biosimilars Revenue Analysis
      • 4.3 G-CSF and G-CSF Biosimilars Price Analysis
      • 4.4 Market Concentration Degree

      5 G-CSF and G-CSF Biosimilars Regional Market Analysis

      • 5.1 G-CSF and G-CSF Biosimilars Production by Regions
        • 5.1.1 Global G-CSF and G-CSF Biosimilars Production by Regions
        • 5.1.2 Global G-CSF and G-CSF Biosimilars Revenue by Regions
      • 5.2 G-CSF and G-CSF Biosimilars Consumption by Regions
      • 5.3 North America G-CSF and G-CSF Biosimilars Market Analysis
        • 5.3.1 North America G-CSF and G-CSF Biosimilars Production
        • 5.3.2 North America G-CSF and G-CSF Biosimilars Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America G-CSF and G-CSF Biosimilars Import and Export
      • 5.4 Europe G-CSF and G-CSF Biosimilars Market Analysis
        • 5.4.1 Europe G-CSF and G-CSF Biosimilars Production
        • 5.4.2 Europe G-CSF and G-CSF Biosimilars Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe G-CSF and G-CSF Biosimilars Import and Export
      • 5.5 China G-CSF and G-CSF Biosimilars Market Analysis
        • 5.5.1 China G-CSF and G-CSF Biosimilars Production
        • 5.5.2 China G-CSF and G-CSF Biosimilars Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China G-CSF and G-CSF Biosimilars Import and Export
      • 5.6 Japan G-CSF and G-CSF Biosimilars Market Analysis
        • 5.6.1 Japan G-CSF and G-CSF Biosimilars Production
        • 5.6.2 Japan G-CSF and G-CSF Biosimilars Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan G-CSF and G-CSF Biosimilars Import and Export
      • 5.7 Southeast Asia G-CSF and G-CSF Biosimilars Market Analysis
        • 5.7.1 Southeast Asia G-CSF and G-CSF Biosimilars Production
        • 5.7.2 Southeast Asia G-CSF and G-CSF Biosimilars Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia G-CSF and G-CSF Biosimilars Import and Export
      • 5.8 India G-CSF and G-CSF Biosimilars Market Analysis
        • 5.8.1 India G-CSF and G-CSF Biosimilars Production
        • 5.8.2 India G-CSF and G-CSF Biosimilars Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India G-CSF and G-CSF Biosimilars Import and Export

      6 G-CSF and G-CSF Biosimilars Segment Market Analysis (by Type)

      • 6.1 Global G-CSF and G-CSF Biosimilars Production by Type
      • 6.2 Global G-CSF and G-CSF Biosimilars Revenue by Type
      • 6.3 G-CSF and G-CSF Biosimilars Price by Type

      7 G-CSF and G-CSF Biosimilars Segment Market Analysis (by Application)

      • 7.1 Global G-CSF and G-CSF Biosimilars Consumption by Application
      • 7.2 Global G-CSF and G-CSF Biosimilars Consumption Market Share by Application (2014-2019)

      8 G-CSF and G-CSF Biosimilars Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Roche
        • 8.3.1 Roche G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.3.2 Roche Product Introduction, Application and Specification
        • 8.3.3 Roche G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Merck & Co.
        • 8.4.1 Merck & Co. G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.4.2 Merck & Co. Product Introduction, Application and Specification
        • 8.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Sanofi
        • 8.5.1 Sanofi G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.5.2 Sanofi Product Introduction, Application and Specification
        • 8.5.3 Sanofi G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Johnson & Johnson
        • 8.6.1 Johnson & Johnson G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Gilead Science
        • 8.7.1 Gilead Science G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.7.2 Gilead Science Product Introduction, Application and Specification
        • 8.7.3 Gilead Science G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 GlaxoSmithKline
        • 8.8.1 GlaxoSmithKline G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 AbbVie
        • 8.9.1 AbbVie G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.9.2 AbbVie Product Introduction, Application and Specification
        • 8.9.3 AbbVie G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Amgen
        • 8.10.1 Amgen G-CSF and G-CSF Biosimilars Production Sites and Area Served
        • 8.10.2 Amgen Product Introduction, Application and Specification
        • 8.10.3 Amgen G-CSF and G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 AstraZeneca
      • 8.12 Bayer

      9 Development Trend of Analysis of G-CSF and G-CSF Biosimilars Market

      • 9.1 Global G-CSF and G-CSF Biosimilars Market Trend Analysis
        • 9.1.1 Global G-CSF and G-CSF Biosimilars Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 G-CSF and G-CSF Biosimilars Regional Market Trend
        • 9.2.1 North America G-CSF and G-CSF Biosimilars Forecast 2019-2025
        • 9.2.2 Europe G-CSF and G-CSF Biosimilars Forecast 2019-2025
        • 9.2.3 China G-CSF and G-CSF Biosimilars Forecast 2019-2025
        • 9.2.4 Japan G-CSF and G-CSF Biosimilars Forecast 2019-2025
        • 9.2.5 Southeast Asia G-CSF and G-CSF Biosimilars Forecast 2019-2025
        • 9.2.6 India G-CSF and G-CSF Biosimilars Forecast 2019-2025
      • 9.3 G-CSF and G-CSF Biosimilars Market Trend (Product Type)
      • 9.4 G-CSF and G-CSF Biosimilars Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 G-CSF and G-CSF Biosimilars Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.

        The global G-CSF and G-CSF Biosimilars market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on G-CSF and G-CSF Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-CSF and G-CSF Biosimilars market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of G-CSF and G-CSF Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their G-CSF and G-CSF Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Roche
        Merck & Co.
        Sanofi
        Johnson & Johnson
        Gilead Science
        GlaxoSmithKline
        AbbVie
        Amgen
        AstraZeneca
        Bayer

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Blood Disorders
        Oncology Diseases
        Chronic And Autoimmune Diseases
        Growth Hormone Deficiencies

        Segment by Application
        Human Growth Hormone
        Erythropoietin
        Monoclonal Antibodies
        Insulin
        Interferon


        Summary:
        Get latest Market Research Reports on G-CSF and G-CSF Biosimilars. Industry analysis & Market Report on G-CSF and G-CSF Biosimilars is a syndicated market report, published as Global G-CSF and G-CSF Biosimilars Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of G-CSF and G-CSF Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,814.00
        4,221.00
        5,628.00
        3,173.61
        4,760.42
        6,347.22
        378,378.00
        567,567.00
        756,756.00
        250,970.65
        376,455.98
        501,941.30
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report